The Joint i3+3 (Ji3+3) design for phase I/II adoptive cell therapy clinical trials

Lin, XL; Ji, Y

Ji, Y (corresponding author), Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020; 30 (6): 993

Abstract

Adoptive cell therapy (ACT), such as chimeric antigen receptor (CAR) T-cell therapy, has demonstrated promising therapeutic effects with potentially n......

Full Text Link